MoneyWorks4Me

Lupin reports over two-fold jump in Q4 consolidated net profit

15 May 2025 Evaluate

Lupin has reported results for fourth quarter (Q4) and year ended March 31, 2025.

The company has reported over three-fold jump in its net profit at Rs 1,291.35 crore for the quarter under review as compared to Rs 384.08 crore for the same quarter in the previous year. The total income of the company increased by 32.31% at Rs 4,534.46 crore for Q4FY25 as compared to Rs 3,427.22 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported over two-fold jump in its net profit at Rs 782.38 crore for fourth quarter ended March 31, 2025 as compared to Rs 368.22 crore for the same quarter in the previous year. The total income of the company increased by 14.71% at Rs 5,724.08 crore for Q4FY25 as compared to Rs 4,990.04 crore for the corresponding quarter previous year.

For the year ended March 31, 2025, the company has reported 70.80% rise in its net profit at Rs 3,972.96 crore as compared to Rs 2,326.09 crore for the previous year. The total income of the company increased by 16.03% at Rs 17,141.55 crore for year under review as compared to Rs 14,773.23 crore for year ended March 31, 2024.

For the year ended March 31, 2025, on the consolidated basis, the company has reported 70.82% rise in its net profit at Rs 3,306.26 crore as compared to Rs 1,935.57 crore for the previous year. The total income of the company increased by 13.77% at Rs 22,903.72 crore for year under review as compared to Rs 20,130.99 crore for year ended March 31, 2024.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..